GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 207 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $6,594,000 | -51.2% | 124,583 | -62.2% | 0.01% | -57.9% |
| Q4 2018 | $13,520,000 | -45.3% | 329,344 | -49.4% | 0.02% | +26.7% |
| Q3 2018 | $24,710,000 | +69.0% | 650,264 | +101.0% | 0.02% | -16.7% |
| Q2 2018 | $14,624,000 | +0.7% | 323,544 | +7.6% | 0.02% | -5.3% |
| Q1 2018 | $14,528,000 | +28.1% | 300,779 | +4.3% | 0.02% | +26.7% |
| Q4 2017 | $11,343,000 | +33.2% | 288,254 | +5.1% | 0.02% | +25.0% |
| Q3 2017 | $8,515,000 | +21.1% | 274,250 | +6.7% | 0.01% | +20.0% |
| Q2 2017 | $7,032,000 | +22.2% | 257,127 | +64.6% | 0.01% | +25.0% |
| Q1 2017 | $5,756,000 | +1241.7% | 156,195 | +426.2% | 0.01% | +700.0% |
| Q4 2016 | $429,000 | -25.1% | 29,682 | +19.3% | 0.00% | 0.0% |
| Q3 2016 | $573,000 | +55.3% | 24,870 | +11.7% | 0.00% | 0.0% |
| Q2 2016 | $369,000 | +132.1% | 22,272 | +122.2% | 0.00% | – |
| Q1 2016 | $159,000 | -50.9% | 10,025 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $324,000 | +9.8% | 10,025 | +43.5% | 0.00% | 0.0% |
| Q3 2015 | $295,000 | – | 6,986 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 177,414 | $14,103,000 | 11.50% |
| Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
| Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
| ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
| STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
| Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
| Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
| Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
| SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
| Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |